Pyng Medical Corp.

Pyng Medical Corp.

September 11, 2009 15:05 ET

Pyng Medical Corp. Announces Resignation of CFO and Corporate Secretary

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 11, 2009) - Pyng Medical Corp. (the "Company") (TSX VENTURE:PYT) reports that Steve Law has resigned from the positions of Chief Financial Officer and Corporate Secretary of the Company. Mr. Law will continue to work with the Board and senior management in support of a smooth transition while he pursues other business interests.

The Company is in the process of searching for new candidates for the positions of Chief Financial Officer and Corporate Secretary. Until a proper replacement for Mr. Law is obtained, the Company's current President and Chief Executive Officer, Robert Di Silvio, will act as the Company's Chief Financial Officer for a temporary period.

Mr. O'Neill stated on behalf of the Board of Directors, "We wish to thank Steve for his contributions and also to wish him well in his future endeavours."

On behalf of the Board of Directors of Pyng Medical Corp.

Kevin O'Neill, Director, Pyng Medical Corp.

Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects", "anticipates", "plans", "intends", "projects", "indicates", and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the Company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and development of new products, including regulatory approval and market acceptance; and seasonality of sales in some products.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

  • Pyng Medical Corp.
    Bob DiSilvio
    1-800-349-7964 (x208)